切换至 "中华医学电子期刊资源库"

中华肺部疾病杂志(电子版) ›› 2022, Vol. 15 ›› Issue (03) : 323 -326. doi: 10.3877/cma.j.issn.1674-6902.2022.03.007

论著

黄芪多糖对铜绿假单胞菌致大鼠肺部感染的作用分析
卢平1,(), 欧立文1, 李牛秀1, 廖彩霞1, 刘红玉1   
  1. 1. 423000 郴州,湘南学院附属医院
  • 收稿日期:2021-10-05 出版日期:2022-06-25
  • 通信作者: 卢平
  • 基金资助:
    湘南学院科研基金项目(C2014-16)

Effect of astragalus polysaccharide on pulmonary infection induced by Pseudomonas aeruginosa in rats

Ping Lu1,(), Liwen Ou1, niuxiu Li1, Caixia Liao1, Hongyu Liu1   

  1. 1. Affiliated Hospital of Xiangnan University Chenzhou 423000, China
  • Received:2021-10-05 Published:2022-06-25
  • Corresponding author: Ping Lu
引用本文:

卢平, 欧立文, 李牛秀, 廖彩霞, 刘红玉. 黄芪多糖对铜绿假单胞菌致大鼠肺部感染的作用分析[J]. 中华肺部疾病杂志(电子版), 2022, 15(03): 323-326.

Ping Lu, Liwen Ou, niuxiu Li, Caixia Liao, Hongyu Liu. Effect of astragalus polysaccharide on pulmonary infection induced by Pseudomonas aeruginosa in rats[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2022, 15(03): 323-326.

目的

分析黄芪多糖(astragalus polysaccharide, APS)对铜绿假单胞菌所致大鼠肺部感染的保护作用。

方法

经气管内注射铜绿假单胞菌制备肺部感染模型,将40只SD雄性大鼠随机分为对照组(Control)、模型组(Model)及APS治疗组(模型+100 mg/kg APS(Model+APS100)及模型+200 mg/kg APS(Model+APS200)组)。造模后24 h处死大鼠,测定肺组织湿干重比(W/D),分别计数及ELISA测定支气管肺泡灌洗液的总炎症细胞数及TNF-α、IL-1β水平,使用Western blot法检测肺组织中NF-κB p65及IκBα蛋白磷酸化水平。

结果

与Control组相比,铜绿假单胞菌显著诱导肺组织W/D增加(P<0.05),增加炎症细胞数(P<0.05),使TNF-α、IL-1β表达(P<0.05),并可诱导NF-κB p65/ IκBα发生磷酸化(P<0.05),而给予APS治疗可明显逆转上述变化(P<0.05),且高剂量组作用明显强于低剂量组(P<0.05)。

结论

APS可能通过抑制p65/ IκBα活性,减少TNF-α及IL-1β的产生,从而减轻铜绿假单胞菌引起的肺部感染。

Objective

To investigate the protective effects of astragalus polysaccharide (APS) on Pseudomonas aeruginosa induced pulmonary infection in rats.

Methods

Forty male SD rats were randomly divided into Control group, Model group and APS treatment group (Model+ 100 mg/kg APS (Model+ APS100) and Model+ 200 mg/kg APS (Model+ APS200). The rats were killed 24 hours after the model established. The wet/dry weight ratio (W/D ratio) of the lung tissue was measured. The number of total inflammatory cells and the levels of TNF-α and IL-1β in the bronchoalveolar lavage fluid were counted and measured by ELISA, respectively. The phosphorylation levels of p65 and IκBα protein in the lung tissue was measured by Western blot.

Results

Compared with Control group, Pseudomonas aeruginosa significantly increased the W/D ratio of lung tissues (P<0.05), the number of inflammatory cells (P<0.05), the expression of TNF-α and IL-1 β (all P<0.05), and the phosphorylation of NF-κB p65/IκBα (all P<0.05). While APS treatment could significantly reverse the above changes (all P<0.05), and the effects of high dose APS was significantly stronger than that of low dose APS (all P<0.05).

Conclusion

It is effective for APS in treatment of lung infectious disease induced by Pseudomonas aeruginosa by inhibiting the activity of NF-κB p65/IκBα and reducing the production of TNF-α and IL-1β.

图1 APS对铜绿假单胞菌肺炎肺W/D比值的影响。与Control组相比,**P<0.01,***P<0.001;与Model组相比,&&P<0.01,&&&P<0.001;与Model+APS100组相比,#P<0.05
图2 APS对铜绿假单胞菌肺炎BALF中TNF-α和IL-1β水平的影响(图A、B)。与Control组相比,a:P<0.05;与Model组相比,b:P<0.05;与Model+APS100组相比,c:P<0.05
图3 APS对铜绿假单胞菌肺炎BALF中炎症细胞数的影响;注:A:总炎症细胞数,B:巨噬细胞数,C:淋巴细胞数,D:中性粒细胞数。与Control组相比,*P<0.05,**P<0.01;与Model组相比,&P<0.05,&&P<0.01;与Model+APS100组相比,#P<0.05
图4 APS抑制铜绿假单胞菌诱导肺部感染的NF-κB p65/IκBα通路活化;注:与Control组相比,a:P<0.05;与Model组相比,b:P<0.05;与Model+APS100组相比,c:P<0.05
1
Imran M, Amjad A, Haidri FR. Frequency of hospital acquired pneumonia and its microbiological etiology in medical intensive care unit[J]. Pak J Med Sci, 2016, 32(4): 823-826.
2
Agrafiotis M, Siempos II, Ntaidou TK, et al. Attributable mortality of ventilator-associated pneumonia: a meta-analysis[J]. Int J Tuberc Lung Dis, 2011, 15(9): 1154-1163, i-v.
3
Kollef MH, Hamilton CW, Ernst FR. Economic impact of ventilator-associated pneumonia in a large matched cohort[J]. Infect Control Hosp Epidemiol, 2012, 33(3): 250-256.
4
张玉江,张 巧,任之栋,等. PSI、APACHEⅡ和SOFA三种评分对医院获得性肺炎预后的评估价值[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(3): 285-288
5
许 静,陈 炜,张 鸿,等. 医院获得性肺炎的治疗及预防进展[J/CD]. 中华肺部疾病杂志(电子版), 2022, 15(1): 123-126.
6
Tsay TB, Jiang YZ, Hsu CM, et al. Pseudomonas aeruginosa colonization enhances ventilator-associated pneumonia-induced lung injury[J]. Respir Res, 2016, 17(1): 101.
7
Ramphal R, Balloy V, Jyot J, et al. Control of Pseudomonas aeruginosa in the lung requires the recognition of either lipopolysaccharide or flagellin[J]. J Immunol, 2008, 181(1): 586-592.
8
El Solh AA, Alhajhusain A. Update on the treatment of pseudomonas aeruginosa pneumonia[J]. J Antimicrob Chemother, 2009, 64(2): 229-238.
9
Jacqueline C, Roquilly A, Desessard C, et al. Efficacy of ceftolozane in a murine model of Pseudomonas aeruginosa acute pneumonia: in vivo antimicrobial activity and impact on host inflammatory response[J]. J Antimicrob Chemother, 2013, 68(1): 177-183.
10
Driscoll JA, Brody SL, Kollef MH. The epidemiology, pathogenesis and treatment of pseudomonas aeruginosa infections[J]. Drugs, 2007, 67(3): 351-368.
11
Li J, Zou M, Dou Q, et al. Characterization of clinical extensively drug-resistant Pseudomonas aeruginosa in the Hunan province of China[J]. Ann Clin Microbiol Antimicrob, 2016, 15(1): 35.
12
Ren Q, Zhao S, Ren C, et al. Astragalus polysaccharide alleviates LPS-induced inflammation injury by regulating miR-127 in H9c2 cardiomyoblasts[J]. Int J Immunopathol Pharmacol, 2018, 32: 2058738418759180.
13
Lu J, Chen X, Zhang Y, et al. Astragalus polysaccharide induces anti-inflammatory effects dependent on AMPK activity in palmitate-treated RAW264.7 cells[J]. Int J Mol Med, 2013, 31(6): 1463-1470.
14
Wang X, Li Y, Yang X, et al. Astragalus polysaccharide reduces inflammatory response by decreasing permeability of LPS-infected Caco2 cells[J]. Int J Biol Macromol, 2013, 61: 347-352.
15
Wang XH, Huang WM. Astragalus polysaccharides exert protective effects in newborn rats with bronchopulmonary dysplasia by upregulating the expression of EGFL7 in lung tissue[J]. Int J Mol Med, 2014, 34(6): 1529-1536.
16
Liu QY, Yao YM, Zhang SW, et al. Astragalus polysaccharides regulate T cell-mediated immunity via CD11c(high)CD45RB(low) DCs in vitro[J]. J Ethnopharmacol, 2011, 136(3): 457-464.
17
Yuan LB, Hua CY, Gao S, et al. Astragalus polysaccharides attenuate monocrotaline-induced pulmonary arterial hypertension in rats[J]. Am J Chin Med, 2017, 45(4): 773-789.
18
Cai S, Li Y, Wang K, et al. Pathogenic Effects of biofilm on pseudomonas aeruginosa pulmonary infection and its relationship to cytokines[J]. Med Sci Monit, 2016, 22: 4869-4874.
19
Wang Q, Ma L, Liu T, et al. TIPE2 suppresses pseudomonas aeruginosa keratitis by inhibiting NF-κB signaling and the infiltration of inflammatory cells[J]. J Infect Dis, 2019, 220(6): 1008-1018.
20
Tak PP, Firestein GS. NF-kappa B: a key role in inflammatory diseases[J]. J Clin Invest, 2001, 107(1): 7-11.
[1] 农云洁, 黄小桂, 黄裕兰, 农恒荣. 超声在多重肺部感染诊断中的临床应用价值[J]. 中华医学超声杂志(电子版), 2024, 21(09): 872-876.
[2] 曾雪灵, 杨思园, 常宇飞, 赵红心, 王凌航. 176例人类免疫缺陷病毒合并肺部感染者呼吸道病原体特点与免疫学特征[J]. 中华实验和临床感染病杂志(电子版), 2024, 18(03): 142-148.
[3] 韦涌涛, 王松霞, 苏爱美, 王东平. 耐碳青霉烯类铜绿假单胞菌耐药性及联合药敏试验研究[J]. 中华实验和临床感染病杂志(电子版), 2024, 18(01): 43-48.
[4] 郑玉, 许振浪, 陈青青. 类鼻疽致肺部感染患者的治疗及药学监护分析一例[J]. 中华肺部疾病杂志(电子版), 2024, 17(04): 670-672.
[5] 王蕊, 林先萍, 李盼盼. 铜绿假单胞菌感染肺炎菌血症危险因素及耐药性分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(03): 478-480.
[6] 罗懿, 王洪武. 宏基因组高通量测序在肺部感染中的应用[J]. 中华肺部疾病杂志(电子版), 2024, 17(02): 320-323.
[7] 徐辉, 杨勇琼, 刘健, 许剑, 江佳莲, 邓正波. s-ChE、PCT、CRP在肺结核中的表达及继发肺部感染的预测意义[J]. 中华肺部疾病杂志(电子版), 2024, 17(02): 292-295.
[8] 郭小琦, 张璞, 李小军, 余明, 王博. 口服醋酸泼尼松联合局部注射曲安奈德对食管早癌ESD术后食管狭窄及肺部感染的预防疗效分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(02): 288-291.
[9] 高瑞, 康迪斯, 秦蘅, 胡月明, 初同伟, 代丽. 加速康复管理改善膝关节置换术后肺部感染并发症和疗效的Meta分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(02): 234-237.
[10] 刘凌卉, 程铃, 张小雪, 肖敏. 环状RNA与肺部感染的研究进展[J]. 中华肺部疾病杂志(电子版), 2024, 17(01): 140-143.
[11] 陈慧, 范婷, 李春花, 黄其密, 陈晓英, 翁启明, 彭茹, 唐思, 何佳霖, 陈庆, 王旖旎, 汤玲一. 重症急性胰腺炎并发肺部感染临床分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(06): 856-859.
[12] 张怡, 郑少琴, 杨莎. 肺部感染为主要表现艾滋病合并马尔尼菲篮状菌病一例[J]. 中华肺部疾病杂志(电子版), 2023, 16(06): 903-905.
[13] 闫晶, 刘磊, 王永红. AECOPD肺部感染控制窗的影响因素分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(05): 715-717.
[14] 蒲洁琨, 褚明娟, 庞茜茜, 张志华, 张鹤鸣, 汤建华. 张家口地区碳青霉烯耐药铜绿假单胞菌耐药性及其机制分析[J]. 中华临床医师杂志(电子版), 2023, 17(12): 1291-1296.
[15] 华美芳, 陈莉, 张峰林, 刘忠. 出血性脑卒中术后并发肺部感染的影响因素分析[J]. 中华脑血管病杂志(电子版), 2024, 18(02): 110-114.
阅读次数
全文


摘要